Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLIMR COPD: GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

NCT07747805 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT07747805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07747805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLIMR COPD: GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD
Lead sponsor
The Cleveland Clinic
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 28, 2026
Completion date
August 15, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, obesity & overweight, sarcopenia